Disulfiram Protects Against Radiation-Induced Intestinal Injury in Mice
Radiation-induced intestinal injury (RIII) occurs after high doses of radiation exposure. RIII restricts the therapeutic efficacy of radiotherapy in cancer and increases morbidity and mortality in nuclear disasters. Currently, there is no approved agent for the prevention or treatment of RIII. Here,...
Main Authors: | Qingwen Yuan, Renjun Peng, Huijie Yu, Sinian Wang, Zhongmin Chen, Suhe Dong, Wei Li, Bo Cheng, Qisheng Jiang, Yuwen Cong, Fengsheng Li, Changzheng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.852669/full |
Similar Items
-
Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells
by: Hao-Zhe Cao, et al.
Published: (2022-05-01) -
Natural radioprotectors on current and future perspectives: A mini-review
by: Pooja Shivappa, et al.
Published: (2022-01-01) -
Edaravone Exerts Protective Effects on Mice Intestinal Injury without Interfering with the Anti-Tumor Effects of Radiation
by: Terufumi Kawamoto, et al.
Published: (2023-06-01) -
Encephalopathy caused by disulfiram
by: R. Sant’Angelo, et al.
Published: (2021-04-01) -
CRX-527 induced differentiation of HSCs protecting the intestinal epithelium from radiation damage
by: Dongshu Liu, et al.
Published: (2022-08-01)